Milwaukee, Wisconsin
June 27, 2008
EMD Crop BioScience
has placed renewed focus on Product Development with the recent
addition of new department goals and members – including a new
director.
The expansion is a demonstration of the company’s commitment to
improving plant health and helping growers improve their
returns, says Patrick Reed, the new Director of EMD Crop
BioScience Product Development for North America.
“One of our main goals is to take the key technologies in our
pipeline and test them into a large field development program,
replicating grower management practices with internal
cooperators, land grants universities, and third party
collaborators,” says Reed. “We are developing the supporting
field data to launch of new and exciting crop-enhancing
technologies for our customers.”
Reed had previously served in various roles with EMD Crop
BioScience and its predecessor companies for more than 17 years.
The additional team members consist of experienced field
technical representatives all over North America.
The Product Development department will focus on the expansion
of seed and foliar applications for LCO Promoter Technology® in
both legume and non-legume crops. The team will also provide
technical assistance for EMD’s field sales team. Another
significant goal is to support the company's lead products:
Optimize® for soybeans and Torque™ IF for corn.
“EMD Crop BioScience has more than 100 years of experience,
product support and proven leading-edge technology that Product
Development will continue to build on,” asserts Reed. “My team
is excited to develop new technologies and bring them to market
as soon as we can in keeping with the company tradition.”
Originally founded as the Nitragin Company in 1898 after a
Milwaukee entrepreneur purchased rights to a commercial process
for the production of nitrogen-fixing rhizobia, Nitragin
remained privately owned until 1982. In 1991 Merck KGaA,
Darmstadt, Germany purchased the business. Now headquartered in
Milwaukee, Wisconsin, EMD Crop BioScience is committed to
advancing crop-enhancing technologies and making these products
available to growers worldwide.
Merck is a global pharmaceutical and chemical company with total
revenues of € 7.1 billion in 2007, a history that began in 1668,
and a future shaped by 31,681 employees in 60 countries. Its
success is characterized by innovations from entrepreneurial
employees. Merck's operating activities come under the umbrella
of Merck KGaA, in which the Merck family holds an approximately
70% interest and free shareholders own the remaining
approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was
expropriated and has been an independent company ever since. |
|
